Selarsdi® (ustekinumab-aekn)
for Ulcerative Colitis

Selarsdi (ustekinumab-aekn) is a biosimilar to Stelara that inhibits IL-12 and IL-23 to reduce inflammation. It treats moderate to severe plaque psoriasis (ages 6+), active psoriatic arthritis, and Crohn's disease or ulcerative colitis in adults.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Ulcerative Colitis - UC